×

Biotech and Pharmaceuticals Pharmaceuticals

  • March 27- Alexion Pharmaceuticals Inc on Monday named former Baxalta head Ludwig Hantson chief executive officer as the rare-disease drug maker looks to steady the ship following the exit of its top management. Hantson will take over from David Brennan, who was named interim chief last year following the departure of Alexion's top executives in the...

  • March 27- Alexion Pharmaceuticals Inc on Monday named former Baxalta head Ludwig Hantson chief executive officer as the rare-disease drug maker looks to steady the ship following the exit of its top management. Hantson will take over from David Brennan, who was named interim chief last year following the departure of Alexion's top executives in the...

  • March 27- Alexion Pharmaceuticals Inc said it named former Baxalta head Ludwig Hantson chief executive officer as the rare-disease drug maker looks to steady the ship following the exit of its top management. David Brennan, former head of British drugmaker AstraZeneca Plc, has been Alexion's interim CEO after David Hallal left the company in December amid...

  • LONDON, March 25- Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs. The decision, announced by the European Medicines Agency on its website, is the latest blow for India's drug-testing...

  • Mad Money Lightning Round

    Jim Cramer rattles off his take on caller favorite stocks, including this concerning energy stock.

  • WASHINGTON— The old and the poor made out great when House Republicans failed Friday to dismantle Barack Obama's Affordable Care Act. The measure would have repealed major parts of Obama's health law, capping future funding for Medicaid and cutting tax increases for high-income families, health insurance companies and drugmakers. That's the tally...

  • March 24- Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws. The U.S. administration has threatened an import tax, while Trump has attacked some of the world's biggest companies, prompting many to make...

  • March 24- Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year.

  • Trump's repeal more of an adjustment

    John Rountree, partner at Novasecta, discusses how the pharmaceutical industry is reacting to U.S. President Donald Trump's delayed health care bill.

  • A first responder for Livingston County Michigan, draws the blood of Amaria Roberson, age 5 of Flint, to screen her blood for lead on January 26, 2016 at Eisenhower Elementary School in Flint, Michigan. Free lead screenings are performed for Flint children 6-years-old and younger, one of several events sponsored by Molina Healthcare following the city's water contamination and federal state of emergency.

    As Republicans tried to muster support for their health-care bill on Thursday, one insurance executive told CNBC the measure is a bad idea.

  • JERUSALEM, March 23- Teva Pharmaceutical Industries' plans to end unprofitable activities and freeze recruitment, but said Israeli media reports of up to 6,000 layoffs were incorrect. Earlier on Thursday, two of Israel's leading financial news websites carried separate reports that Teva, the world's biggest generic drug maker and Israel's largest company,...

  • March 22- Generic drugmaker Mylan NV has recalled about 81,000 EpiPen devices in countries outside the United States, following two reports of the life-saving allergy shot failing to work in emergencies. The recall affects devices distributed in Australia, New Zealand, Europe and Japan only, according to the company. The U.S. drugmaker, which is the focus of...

  • Mylan EpiPen

    Mylan has recalled about 81,000 EpiPen devices outside the United States, following two reports of product failure.

  • March 22- Generic drugmaker Mylan NV has recalled about 81,000 EpiPen devices in countries outside the United States, following two reports of the life-saving allergy shot failing to work in emergencies. The recall affects devices distributed in Australia, New Zealand, Europe and Japan only, according to the company. The U.S. drugmaker, which is the focus of...

  • March 22- Generic drugmaker Mylan NV has recalled some EpiPen devices in countries outside the United States, following two reports of the life-saving allergy shot failing to work in emergencies. The recall includes EpiPen devices issued in Ireland, Australia, Finland, Denmark and some other European nations. The U.S. drugmaker, which is the focus of multiple...

  • As SEC chairman, Clayton would be in charge of, among other things, protecting investors from wrongdoing on Wall Street. He would oversee the enforcement of rules written by the SEC under the law that reshaped the regulation of banks and Wall Street after the 2008 financial crisis and the Great Recession. And he would take part in deciding on enforcement actions...

  • FRANKFURT, March 22- With rivals joining forces all around, Germany's BASF has been eyeing a surprise foray into generic pesticides, although the issue is on hold while it looks to snap up assets being spun off in those mergers. BASF is the only player left among the top six in a global seeds and pesticides market worth over $100 billion that has not paired up with a...

  • The U.S. Food and Drug Administration's ban on Divi's Unit II factory in the eastern Indian state of Vizag- news of which was posted on the FDA website and seen by Reuters on Wednesday- is the second setback this month for India's drugs industry. The FDA found violations of manufacturing standards at Dr Reddy's Laboratories Ltd's drug plant, also in Vizag, during an...

  • The city alleged that Purdue knowingly allowed pills to be funneled into the black market and into the city and did nothing to stop it. The city's lawsuit which accuses Purdue of gross negligence and nuisance was initially filed in state court but has moved to federal court in Seattle. Purdue makes several arguments in asking U.S.

  • Tourists take a picture with the market bull near the New York Stock Exchange.

    See which stocks are posting big moves after the bell.